<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01878240</url>
  </required_header>
  <id_info>
    <org_study_id>P12-37813003/2012A01258-35</org_study_id>
    <secondary_id>IDRCB 2012-A0125-35</secondary_id>
    <nct_id>NCT01878240</nct_id>
  </id_info>
  <brief_title>Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac</brief_title>
  <acronym>SCOPE1</acronym>
  <official_title>Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Chirurgical Marie Lannelongue</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut Mutualiste Montsouris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henri Mondor University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Unité de Recherche Clinique du Centre chirurgical marie Lannelongue</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Chirurgical Marie Lannelongue</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abdominal aortic aneurysms (AAAs) continue to be a leading cause of death in older age
      groups. In the 60-85 year-old population, AAA represents the 14th-leading cause of death.
      Federal funding through Medicare has been allocated for early detection using abdominal
      ultrasound screening programs. Despite these more aggressive screening programs and concerted
      efforts by surgeons for timely repair, the incidence of ruptured AAA has continued to
      increase.

      Endovascular aneurysm repair (EVAR) has been the most common type of repair since 2006.
      Multiple studies reflecting decreased perioperative morbidity and mortality over open repair
      make this an attractive option for patients. EVAR requires more intensive follow-up than
      standard open surgical repair, however. Secondary interventions are more common to maintain
      &quot;seal&quot; of the endograft within the aorta and subsequent exclusion of the aneurysmal
      component.

      The term endoleak is specific to EVAR, and describes the primary means by which endografts
      fail. Type I endoleaks occur because of inadequate graft seal proximally or distally,
      resulting in perigraft flow and aneurysm sac pressurization. Type II endoleaks occur when
      branch arteries arising from the aneurysmal aorta back-bleed into the aneurysm sac due to
      collateral flow. Type III endoleaks occur when flow persists between segments of a modular
      graft. Type IV endoleaks occur when flow persists through endograft material (graft
      porosity). Type V endoleaks have also been called &quot;endotension&quot;, and occur when
      pressurization of the sac occurs in the absence of any demonstrable endoleak. Type I and Type
      III endoleaks are most concerning for rupture, although persistent Type II endoleaks can also
      lead to aneurysm rupture and premature death.

      The most common method of EVAR follow-up is computed tomographic angiography (CTA). These
      studies allow accurate measurement of aneurysm sac diameters and volumes. They also are
      highly sensitive and specific for endoleaks. Type II endoleaks are treated if they remain
      persistent and are present in the setting of aneurysm sac enlargement. Type I and III
      endoleaks are immediately treated when identified. Type IV endoleaks are rarely seen with
      current endograft technology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Objectives:

      The purpose of the current study is to compare the level of endoleaks between group 1 and 2
      at 1, 6, 12 and 24 months.

      Study Design Prospective interventional study, multicenter, open, randomized trial comparing
      the type II endoleak level in patients who benefited the endovascular AAA repair (group 1:
      without coils) versus combination with coil embolization of the aneurysmal sac (group II:
      with coils).

      The choice of treatment is randomized.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation at one month the presence or absence of endoleak type II in all patients for each group by Computer Tomography and Doppler.</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>• Evaluation at 6, 12 and 24 months by CT and doppler: -The rate of type II endoleak</measure>
    <time_frame>6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Mortality and morbidity .</measure>
    <time_frame>1, 6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Number of additional procedures -endovascular -surgical</measure>
    <time_frame>1, 6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Complications of endovascular procedures away from the EVAR -Thrombosis of leg -Limb occlusion -Evolution of the aneurysmal neck</measure>
    <time_frame>1, 6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Monitoring of renal function (creatinine clearance).</measure>
    <time_frame>1, 6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Evaluation at 6, 12 and 24 months by CT and doppler: -Measurement of the maximum transverse aneurysm diameter</measure>
    <time_frame>6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Evaluation at 6, 12 and 24 months by CT and doppler: -volumetric measurement of the sac aneurysmal</measure>
    <time_frame>6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>EVAR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endovascular repair of an Abdominal Aortic Aneurysm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coil embolization during EVAR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>coil embolization during Endovascular repair</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EVAR without coils embolization/ Coils embolization during EVAR</intervention_name>
    <arm_group_label>EVAR</arm_group_label>
    <arm_group_label>Coil embolization during EVAR</arm_group_label>
    <other_name>Coil embolization during endovascular Aortic Abdominal Aneurysm repair</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Carrying a sub-renal AAA with a diameter of at least 5 cm at a rate of growth or
             greater 1cm/an diameter (according to Haute Autorité de Santé (HAS) recommendations
             toE VAR treatment),

          -  Patients with high risk of type II endoleak (clouding of an aortic aneurysm sac by
             collateral branch), respondents with at least one of the following criteria on the
             scanner to be included:

               -  The presence of a pair of permeable lumbar arteries.

               -  The presence of a patent inferior mesenteric artery.

        Exclusion Criteria:

          -  Sub renal Collet &lt;10 mm

          -  Angulated &gt; 60 °

          -  No collateral arising from the aneurysmal sac

          -  Iliac aneurysms associated

          -  Ruptured AAA

          -  Pregnant Women

          -  Lack of consent

          -  Lack of social security
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique FABRE, Vascular surgeon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Chirurgical Marie Lannelongue</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique FABRE, MD Vascular Surgeon</last_name>
    <phone>+ 33(0) 1 40 94 85 76</phone>
    <email>d.fabre@ccml.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aminata TRAORE</last_name>
    <phone>+ 33 (0) 1 40 94 28 00</phone>
    <email>a.traore@ccml.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Henri Mondor - APHP</name>
      <address>
        <city>Creteil</city>
        <state>Ile de France</state>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic COCHENNEC-PALIWODA, MD, Vascular Surgeon</last_name>
      <email>cochennecf@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Aminata TRAORE</last_name>
      <phone>+ 33 (0) 1 40 94 28 00</phone>
      <email>a.traore@ccml.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Frederic COCHENNEC-PALIWADA, MD, Vascular Surgeon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Chirurgical MarieLannelongue</name>
      <address>
        <city>Le Plessis Robinson</city>
        <state>Ile de France</state>
        <zip>92350</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique FABRE, MD, Vascular Surgeon</last_name>
      <phone>+ 33 (0) 1 40 94 85 76</phone>
      <email>d.fabre@ccml.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aminata TRAORE</last_name>
      <phone>+33 (0) 1 40 94 28 00</phone>
      <email>a.traore@ccml.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Dominique FABRE, MD, Vascular Surgeon</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claude Angel, MD, Radiologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Mutualiste Montsouris</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Myriam COMBES, MD, Vascular Surgeon</last_name>
      <email>myriam.combes@imm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aminata TRAORE</last_name>
      <phone>+ 33 (0) 1 40 94 28 00</phone>
      <email>a.traore@ccml.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Myriam COMBES, MD, Vascular Surgeon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoit BOURA, MD, Vascular Surgeon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.ccml.fr</url>
  </link>
  <results_reference>
    <citation>Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg FT Jr, Kohler TR, Kougias P, Jean-Claude JM, Cikrit DF, Swanson KM; OVER Veterans Affairs Cooperative Study Group. Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. N Engl J Med. 2012 Nov 22;367(21):1988-97. doi: 10.1056/NEJMoa1207481.</citation>
    <PMID>23171095</PMID>
  </results_reference>
  <results_reference>
    <citation>Jackson RS, Chang DC, Freischlag JA. Comparison of long-term survival after open vs endovascular repair of intact abdominal aortic aneurysm among Medicare beneficiaries. JAMA. 2012 Apr 18;307(15):1621-8. doi: 10.1001/jama.2012.453.</citation>
    <PMID>22511690</PMID>
  </results_reference>
  <results_reference>
    <citation>Stather PW, Sidloff D, Dattani N, Choke E, Bown MJ, Sayers RD. Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm. Br J Surg. 2013 Jun;100(7):863-72. doi: 10.1002/bjs.9101. Epub 2013 Mar 8. Review.</citation>
    <PMID>23475697</PMID>
  </results_reference>
  <results_reference>
    <citation>Piazza M, Frigatti P, Scrivere P, Bonvini S, Noventa F, Ricotta JJ 2nd, Grego F, Antonello M. Role of aneurysm sac embolization during endovascular aneurysm repair in the prevention of type II endoleak-related complications. J Vasc Surg. 2013 Apr;57(4):934-41. doi: 10.1016/j.jvs.2012.10.078. Epub 2013 Feb 4.</citation>
    <PMID>23384494</PMID>
  </results_reference>
  <results_reference>
    <citation>Schanzer A, Greenberg RK, Hevelone N, Robinson WP, Eslami MH, Goldberg RJ, Messina L. Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair. Circulation. 2011 Jun 21;123(24):2848-55. doi: 10.1161/CIRCULATIONAHA.110.014902. Epub 2011 Apr 10. Erratum in: Circulation. 2012 Jan 17;125(2):e266.</citation>
    <PMID>21478500</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2013</study_first_submitted>
  <study_first_submitted_qc>June 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2013</study_first_posted>
  <last_update_submitted>May 21, 2017</last_update_submitted>
  <last_update_submitted_qc>May 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vascular surgery</keyword>
  <keyword>Abdominal Aortic aneurysm</keyword>
  <keyword>endovascular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Endoleak</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

